Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases
Bioconjugate Chemistry · 20.11.2024 · 35 (11) · 1687-1698
DOI: 10.1021/acs.bioconjchem.4c00414 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, online erschienen am 08.10.2024. Verfasst von Juntao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Blood-Brain Barrier, Brain Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hubei University of Science and Technology, Cancer Institute NSW, Guangzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Inflammation within the brain is a hallmark of a wide range of brain diseases. The complex role of inflammatory processes in these conditions suggests that neuroinflammation could be a valuable therapeutic target. While several promising anti-inflammatory agents have been identified, their clinical application in brain diseases is often hampered by the inability to cross the blood-brain barrier (BBB) and reach therapeutically effective concentrations at the pathological sites. This limitation highlights the urgent need for effective BBB-penetrating drug delivery systems designed to target brain inflammation. This review critically examines the recent advances over the past five years in drug delivery strategies aimed at mitigating brain inflammation in Alzheimer's disease and ischemic stroke─two of the leading causes of death and disability worldwide. Additionally, we address the key challenges in this field, offering insights into future directions for targeting neuroinflammation in the treatment of brain diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Nuclear Technology and Chemistry & Biology, Hubei University of Science and Technology, Xianning, 437100, China.
- School of Pharmacy, Henan University, Kaifeng, 475001, China.
- Yazhou Bay Innovation Institute, Hainan Tropical Ocean University, Sanya, 572022, China.
- Macquarie Medical School, Macquarie University, Sydney, New South Wales 2109, Australia.
- Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China.
ORCID-Profile: Juntao Wang, Wubo Wan, Haijun Han
Förderung
- Hubei University of Science and Technology
- Cancer Institute NSW
- Guangzhou Municipal Science and Technology Bureau
- Sanya Yazhou Bay Science and Technology City
- Scientific Research Foundation of Hainan Tropical Ocean University
Zitieren
APA
Wang, J., Jia, R., Wan, W., Han, H., Wang, G., Li, Z., & Li, J. (2024). Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases. Bioconjugate Chemistry, 35(11), 1687-1698. https://doi.org/10.1021/acs.bioconjchem.4c00414
Vancouver
Wang J, Jia R, Wan W, Han H, Wang G, Li Z, et al. Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases. Bioconjugate Chemistry. 2024;35(11):1687-1698. doi:10.1021/acs.bioconjchem.4c00414
BibTeX
@article{Wang2024,
author = {Wang, Juntao and Jia, Ruiqin and Wan, Wubo and Han, Haijun and Wang, Guoying and Li, Zhen and Li, Jia},
title = {Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases},
journal = {Bioconjugate Chemistry},
year = {2024},
volume = {35},
number = {11},
pages = {1687--1698},
doi = {10.1021/acs.bioconjchem.4c00414}
}
EUVIMED